205 related articles for article (PubMed ID: 21354436)
1. Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity.
Herrera JL; Fernandez C; Diaz M; Cury D; Marin R
Steroids; 2011 Aug; 76(9):840-4. PubMed ID: 21354436
[TBL] [Abstract][Full Text] [Related]
2. Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer's disease.
Herrera JL; Diaz M; Hernández-Fernaud JR; Salido E; Alonso R; Fernández C; Morales A; Marin R
J Neurochem; 2011 Mar; 116(5):820-7. PubMed ID: 21214547
[TBL] [Abstract][Full Text] [Related]
3. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
[TBL] [Abstract][Full Text] [Related]
4. Voltage-dependent anion channel (VDAC) participates in amyloid beta-induced toxicity and interacts with plasma membrane estrogen receptor alpha in septal and hippocampal neurons.
Marin R; Ramírez CM; González M; González-Muñoz E; Zorzano A; Camps M; Alonso R; Díaz M
Mol Membr Biol; 2007; 24(2):148-60. PubMed ID: 17453421
[TBL] [Abstract][Full Text] [Related]
5. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile.
Zhao L; O'Neill K; Brinton RD
J Pharmacol Exp Ther; 2006 Dec; 319(3):1124-32. PubMed ID: 16951259
[TBL] [Abstract][Full Text] [Related]
6. New findings concerning vertebrate porin II--on the relevance of glycine motifs of type-1 VDAC.
Thinnes FP
Mol Genet Metab; 2013 Apr; 108(4):212-24. PubMed ID: 23419876
[TBL] [Abstract][Full Text] [Related]
7. Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease.
O'Neill K; Chen S; Diaz Brinton R
Exp Neurol; 2004 Aug; 188(2):268-78. PubMed ID: 15246826
[TBL] [Abstract][Full Text] [Related]
8. Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
Du B; Ohmichi M; Takahashi K; Kawagoe J; Ohshima C; Igarashi H; Mori-Abe A; Saitoh M; Ohta T; Ohishi A; Doshida M; Tezuka N; Takahashi T; Kurachi H
J Endocrinol; 2004 Dec; 183(3):605-15. PubMed ID: 15590986
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptors in lipid raft signalling complexes for neuroprotection.
Marin R; Marrero-Alonso J; Fernandez C; Cury D; Diaz M
Front Biosci (Elite Ed); 2012 Jan; 4(4):1420-33. PubMed ID: 22201966
[TBL] [Abstract][Full Text] [Related]
10. Membrane-initiated signaling of estrogen related to neuroprotection. "Social networks" are required.
Marin R; Marrero-Alonso J; Fernández C; Cury D; Díaz M
Horm Mol Biol Clin Investig; 2011 Oct; 7(3):393-401. PubMed ID: 25961340
[TBL] [Abstract][Full Text] [Related]
11. Novel mechanisms of estrogen action in the brain: new players in an old story.
Toran-Allerand CD; Singh M; Sétáló G
Front Neuroendocrinol; 1999 Apr; 20(2):97-121. PubMed ID: 10328986
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease.
Amtul Z; Wang L; Westaway D; Rozmahel RF
Neuroscience; 2010 Aug; 169(2):781-6. PubMed ID: 20493928
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane.
Sheldahl LC; Marriott LK; Bryant DM; Shapiro RA; Dorsa DM
Minerva Endocrinol; 2007 Jun; 32(2):87-94. PubMed ID: 17557034
[TBL] [Abstract][Full Text] [Related]
14. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
Xu H; Wang R; Zhang YW; Zhang X
Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
[TBL] [Abstract][Full Text] [Related]
15. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology.
Simpkins JW; Wen Y; Perez E; Yang S; Wang X
Ann N Y Acad Sci; 2005 Jun; 1052():233-42. PubMed ID: 16024766
[TBL] [Abstract][Full Text] [Related]
16. Membrane cholesterol as a mediator of the neuroprotective effects of estrogens.
Peri A; Benvenuti S; Luciani P; Deledda C; Cellai I
Neuroscience; 2011 Sep; 191():107-17. PubMed ID: 21396986
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
[TBL] [Abstract][Full Text] [Related]
18. VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease.
Ramírez CM; González M; Díaz M; Alonso R; Ferrer I; Santpere G; Puig B; Meyer G; Marin R
Mol Cell Neurosci; 2009 Nov; 42(3):172-83. PubMed ID: 19595769
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Abeta-induced neurotoxicity by estrogen receptor alpha and other associated proteins in lipid rafts.
Marin R; Ramírez C; Morales A; González M; Alonso R; Díaz M
Steroids; 2008 Oct; 73(9-10):992-6. PubMed ID: 18242653
[TBL] [Abstract][Full Text] [Related]
20. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
